ELAN
Elanco Animal Health (NYSE: ELAN) announced that its Credelio Quattro (lotilaner, moxidectin, praziquantel,...
Article Summary
HOLD- Elanco Animal Health (NYSE: ELAN) announced that its Credelio Quattro (lotilaner, moxidectin, praziquantel, and pyrantel chewable tablets) kills ticks faster than Simparica Trio (sarolaner and moxIDectin) and NexGard Plus (afoxolaner/moxidECTin/pyrantal) faster than competitors, demonstrating that lotilaner in the product significantly outperforms both products in the first 8 to 12 hours of tick infestation.
- The product was the only product tested to achieve significant initial tick reduction within just 8 hours of infestation, with the rapid speed of kill maintained from the beginning of the month through Day 28 providing consistent protection for the entire dosing interval.
- The longer a tick is attached to a dog, the more likely it is to transmit dangerous diseases like Lyme disease and anaplasmosis, according to Elanco Animal Health.
Free users see 3 BUY signals per day. Premium unlocks all of them, plus instant email alerts.
See Plans
Growth Stock Scoring Breakdown
| METRIC | VALUE | WEIGHT | ANALYSIS |
|---|---|---|---|
| Sales Growth TTM ? | 10.5% | 25% | 50.0 ptsMeets Minimum (10.5%) - Passes screener |
| EPS Growth Next 5Y ? | 13.4% | 25% | 35.0 ptsBelow Screener (13.4%) - Modest outlook |
| Target Price Upside ? | 20.9% | 20% | 70.0 ptsGood Upside (20.9%) - Target: $30.23 vs Current: $25.00 |
| Gross Margin % ? | 43.8% | 15% | 60.0 ptsSolid (43.8%) - Decent margins |
| Drawdown from 52-Wk High ? | -9.8% | 15% | 20.0 ptsBarely a Dip (-9.8%) - Near recent highs |
Disclaimer: This rating is for informational purposes only and is not financial advice.
All data sourced from Finviz.
Always conduct your own research and consult with a financial advisor before making investment decisions.
Past performance does not guarantee future results.
About ELAN
- Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals worldwide.
- The company offers pet health products, such as parasiticides, vaccines, and therapeutics that protect pets from fleas, ticks, and internal parasites under the Seresto, K-9 Advantage, Advantix, and Advocate trademarks; prescription parasiticide products, an over-the-counter treatments for the prevention and elimination of fleas and ticks under the Credelio Family, Interceptor Plus, Drontal family, and Drontal Plus; vaccines portfolio that provides differentiated prevention coverage for a number of important pet health risks; and therapeutics portfolio for the treatment of pain, otitis, cardiovascular, and dermatology indications, as well as osteoarthritis for dogs and cats under the Galliprant trademark.
- It also provides farm animal products that help farmers improve animal health and wellbeing, and raise livestock, such as cattle, swine, and poultry.
- In addition, the company offers medicated feed additives, injectable antibiotics, vaccines, insecticides and enzymes, and others under the Rumensin, Baytril, and Experior trademarks for cattle; and under the Maxiban and Monteban trademarks for the control and prevention of intestinal disease in poultry.
- Further, it offers other pet health products for cats and dogs under the Atopica, Milbemax, Onsior, and Tru Family trademarks; and other farm animal products for poultry, cattle, and swine under the AviPro, Catosal, Denagard, Hemicell, Pulmotil, and Surmax tradmarks.
- The company sells its products to third-party distributors and independent retailers; and directly to farm animal producers and veterinarians.
- Elanco Animal Health Incorporated was founded in 1954 and is headquartered in Indianapolis, Indiana.